Related Experiment Video
Updated: Jul 18, 2026

Visualization of Bacterial Resistance using Fluorescent Antibiotic Probes
Published on: March 2, 2020
Antibiotic-resistant Campylobacter: could efflux pump inhibitors control infection?
Teresa Quinn1, Jean-Michel Bolla, Jean-Marie Pagès
1Centre for Food Safety, School of Agriculture, Food Science and Veterinary Medicine, University College Dublin Belfield, Dublin 4, Ireland.
Abstract:
Campylobacter is the most common cause of bacterial gastroenteritis in the world. Poultry is the main reservoir of human infections. The widespread use of antibiotics in agriculture and veterinary medicine has resulted in the emergence of an increasing number of antibiotic-resistant Campylobacter strains that can be transmitted to humans through the food chain. Of particular concern to public health is the prevalence of resistance to macrolides and fluoroquinolones that are used in the treatment of life-threatening campylobacteriosis. The CmeABC efflux system has been shown to contribute to the intrinsic and acquired resistance to these antibiotics. In addition, by mediating resistance to bile, it is essential for colonization of the chicken gut in vivo. Inhibition of CmeABC may provide an effective means of reversing antibiotic resistance and decreasing the transmission of Campylobacter via the food chain. This would positively impact on public health by decreasing the morbidity, mortality and increased healthcare costs associated with the treatment of antibiotic-resistant Campylobacter.
Related Concept Videos
Inhibitors of Bacterial DNA Synthesis
Development of Antibiotic Resistance
Mechanism of Antibiotic Resistance in MRSA
Drugs Affecting GI Tract Motility: Antimicrobials as Antidiarrheal Agents
Inhibitors of Bacterial Protein Synthesis
Clinical Significance of Antibiotic Resistance
